WASHINGTON — Cosmetic drug and device maker Allergan Inc. says it has received approval to market its stomach-shrinking Lap-Band to millions more patients who are less obese than those currently using the device.
The Food and Drug Administration expanded approval to patients with a body mass index between 30 and 40 and one weight-related medical condition, such as diabetes. Patients must also have previously attempted other weight loss strategies, like diet and exercise.
No comments:
Post a Comment